
NAPOLI 3, POUT, & Ivosidenib - Azole DDIs
OncoPharm
00:00
POUT disease‑free survival benefit
John summarizes POUT's 5‑year disease‑free survival improvement from 45% to 62% with adjuvant platinum‑gemcitabine.
Play episode from 10:05
Transcript

John summarizes POUT's 5‑year disease‑free survival improvement from 45% to 62% with adjuvant platinum‑gemcitabine.